๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Effect of cationized gelatins on the paracellular transport of drugs through caco-2 cell monolayers

โœ Scribed by Toshinobu Seki; Hiroshi Kanbayashi; Tomonobu Nagao; Sumio Chono; Yasuhiko Tabata; Kazuhiro Morimoto


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
163 KB
Volume
95
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.

โœฆ Synopsis


Cationized gelatins, candidate absorption enhancers, were prepared by addition of ethylenediamine or spermine to gelatin and the effects of the resulting ethylenediaminated gelatin (EG) and sperminated gelatin (SG) on the paracellular transport of 5(6)-carboxyfluorescein (CF), FITC-dextran-4 (FD4), and insulin through caco-2 cell monolayers were examined. The Renkin function was used for characterization of the paracellular pathway and changes in the pore radius (R) and pore occupancy/ length ratio ("/L) calculated from the apparent permeability coefficients (P app ) of CF and FD4 are discussed. Ethylenediaminetetraacetic acid (EDTA) increased the R of the caco-2 cell monolayer and the P app of all compounds examined was markedly increased by the addition of EDTA. On the other hand, EG and SG did not increase R and their enhancing effects were not as strong as those of EDTA. The increase in "/L could be the enhancing mechanism for the cationized gelatins. The number of pathways for water-soluble drugs, such as CF and FD4, in the caco-2 monolayers could be increased by the addition of the cationized gelatins. The ratios of the permeability coefficients of insulin (observed/ calculated based on the Renkin function) suggest that insulin undergoes enzymatic degradation during transport which is not inhibited by enhancers.


๐Ÿ“œ SIMILAR VOLUMES


Effects of poly(ethylene glycol) on effl
โœ Erin D. Hugger; Kenneth L. Audus; Ronald T. Borchardt ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 285 KB

Poly(ethylene glycol) (PEG) is an excipient commonly used in pharmaceutical formulations to increase the aqueous solubility of drugs intended for oral administration. High concentrations of PEG are often used to solubilize drug candidates for in vitro experiments in cell culture (e.g., Caco-2 cell p

Experimental demonstration of the unstir
โœ Kazumasa Naruhashi; Ikumi Tamai; Qing Li; Yoshimichi Sai; Akira Tsuji ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 86 KB

We previously demonstrated that P-glycoprotein and MRP2 contribute to the secretory transport of grepafloxacin in the small intestine. Although inhibitors of these secretory transporters increased absorptive transport of grepafloxacin, secretory transport was not altered in Caco-2 cells, as determin

Transport of octreotide and evaluation o
โœ Farid A. Dorkoosh; Corine A.N. Broekhuizen; Gerrit Borchard; Morteza Rafiee-Tehr ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 330 KB

The purpose of this study was to investigate the mechanism of opening of tight junctions in Caco-2 cell monolayers using superporous hydrogel (SPH) and SPH composite (SPHC) polymers as permeation enhancers for peptide drug delivery. Moreover, the transport of octreotide across Caco-2 cell monolayers

The effect of co-administered flavonoids
โœ Walter Brand; Beatriz Padilla; Peter J. van Bladeren; Gary Williamson; Ivonne M. ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 303 KB

## Abstract Metabolism by phase II enzymes and transport from intestinal cells back into the lumen by ATP binding cassette (ABC) transporters limits the bioavailability of the flavanone hesperetin, the aglycone of hesperidin. This study investigates to what extent other flavonoids modulate the meta